In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 104 for your search:
Drug:  methylprednisolone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066016, P30CA016059, MCV-CCHR-9504-2X, DUMC-75951, NCI-G98-1388, NCT00003187

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: SEG-78ALL333

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: SAFR-CT-MM-1

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO268, NCI-V84-0067

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: CCG-945

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO270, NCI-V84-0070

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 14 to 55
Sponsor:
Protocol IDs: OSU-84HO226, NCI-V85-0224

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 55 and under
Sponsor:
Protocol IDs: FHCRC-431, NCI-V89-0262

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: CCG-921

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 51
Sponsor: NCI
Protocol IDs: SWOG-8612

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DM-8684, NCI-V87-0166

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: NCI-D81-011-693, HOG-8130

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8711

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: EORTC-58881, NCI-T90-0065A

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DM-88150, NCI-V89-0034

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: MDA-DM-88089, NCI-V89-0031

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: CCG-1901

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: ARG-GATLA-6-M-89, NCI-F92-0005

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor:
Protocol IDs: GER-GPOH-COALL-05-92, EU-92003

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 5 to 55 preferred
Sponsor: NCI
Protocol IDs: MSKCC-93045, NCI-H93-0293, NCT00002534

21.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01149, ENTERON-00-02, NCI-G02-2098, RPCI-DS-01-09, NCT00043147

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: 05-001 / CDR0000513019, P01CA068484, P30CA006516, DFCI-05001, NCT00400946

23.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Closed
Age: 18 to 80
Sponsor: Other
Protocol IDs: PETAL trial, EudraCT-Number 2006-001641-33, Krebshilfe Grant 107592, NCT00554164

24.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: OPI 07-005, 2007-005617-19, NCT00676936

25.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2009-00312, CDR0000600217, COG-AALL0622, AALL0622, U10CA098543, NCT00720109
1     
New Search